As per a recent study released by Maximize Market Research, titled, “Antacid Market,” The Antacid Market, size was valued at USD 7.63 Bn. in 2023 and the total Antacid Market revenue is expected to grow at 4.5 % from 2024 to 2030, reaching nearly USD 10.39 Bn.
Antacid Market Overview:
The Antacids Market is witnessing steady growth, driven by increasing incidences of acid-related digestive disorders such as heartburn, gastroesophageal reflux disease (GERD), and indigestion. Lifestyle factors—such as diets high in spicy or acidic foods, late-night meals, stress, and sedentary behavior—are contributing to greater discomfort and prompting consumers to seek fast relief. Over-the-counter (OTC) antacid products have become widely adopted for symptom relief, as people often prefer accessible, non-prescription solutions for mild to moderate acid disorders.
Demographic changes also support this trend, especially aging populations in many countries. Older adults are more prone to acid secretion changes, gastritis, and GERD, which increases demand for antacids. Meanwhile, innovation in formulation (chewables, liquids, effervescent tablets) and improved packaging, taste, and usability are helping manufacturers appeal to broader consumer groups.
Download a Free Sample Report Today :https://www.maximizemarketresearch.com/request-sample/100180/
Antacid Market Dynamics
A key driver is the convenience and accessibility of OTC antacids. Consumers are increasingly relying on self-medication for mild acid-related symptoms, bypassing doctor visits and opting for readily available products in pharmacies, supermarkets, and online channels. This trend is supported by user awareness programs about digestive health and increased public health communication about symptoms and treatment options.
Another strong dynamic is product innovation and diversification in formulation and active ingredients. Brands are launching new antacid formulations—combination products, alginate-based, anti-reflux raft formulations, flavored chewables, soft gels, liquids—that differentiate on rapid relief, ease of use, and tolerability. Simultaneously, calcium carbonate, magnesium hydroxide, and other neutralizers remain staples, but consumer preferences are shifting slightly toward formulations that offer better sensory attributes (taste, texture) and ease of administration.
Antacid Market Outlook and Future Trends :
In coming years, online pharmacies and e-commerce are expected to play a larger role in how consumers purchase antacids. The ease of ordering, home delivery, and wider product variety are pushing online channels to grow at faster rates than some traditional retail ones. This is especially true in regions with good logistics and internet penetration.
Another trend is continued emphasis on natural, herbal, or anti-reflux dual-action products. For example, products combining alginate with bicarbonate or newer anti-reflux raft side effects are gaining traction. Formulation science is evolving toward products that not only neutralize acid but also offer protective barriers, taste masking, and quicker onset of relief. Companies are also investing in better packaging and portable formats to enhance compliance and appeal.
Antacid Market Regional Insights:
North America holds a large share of the antacids market, supported by high prevalence of acid-related disorders, strong awareness, ease of OTC access, and high income levels. The United States in particular shows strong consumption of OTC antacids, aided by well-established retail pharmacy and online prescription/OTC frameworks. The aging population also contributes significantly to demand.
In Asia-Pacific, growth is expected to be among the fastest globally. Rapid urbanization, changing dietary habits (more spicy, processed foods), increasing awareness of digestive health, growing healthcare infrastructure, and better access to OTC drugs are fueling demand. Countries like India, China, and others are showing significant growth in retail pharmacy networks and online medicine access, which helps antacid products reach more consumers.
Antacid Market Segmentation
by Dosage Form
Tablet
Liquid
Powder
Others
by Drug Class
Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
by Distribution Channel
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Some of the current players in the Antacid Market are:
1. Abbott Laboratories (US)
2. WellSpring Pharmaceutical Corporation (US)
3. Advance Pharmaceutical Inc. (US)
4. CVS Pharmacy, Inc. (US)
5. Safetec of America, Inc. (US)
6. Johnson & Johnson (US)
7. Mylan N.V. (US)
8. Pfizer Inc (US)
9. Bristol Myers Squibb Company (US)
10.Procter & Gamble (US)
11.Boehringer Ingelheim International GmbH (Germany)
12.Fresenius Kabi AG (Germany)
13.Bayer AG (Germany)
14.Haleon plc (UK)
15.GSK Plc. (UK)
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 [email protected]
